Uncovering Barriers to Timely Biomarker Testing in Cancer Care
Read time: 2 minutes. Comprehensive biomarker testing is one of the most powerful tools in modern lung cancer care, guiding treatment decisions and improving patient outcomes. Yet
Research Blogs
-
-
Celebrating Progress in Lung Cancer: From Detection to Survivorship
Read time: 2 minutes. Over the past twenty years, lung cancer research and care have entered a new era. One filled with hope, innovation, and progress that is transforming what it -
Removing Obstacles to Drive Timely Precision Medicine for Patients
Read time: 3 minutes. Timely comprehensive biomarker testing has become the cornerstone of precision medicine in lung cancer care. For people diagnosed with non–small cell lung -
Low-Dose Computed Tomography and Beyond: Advances in the Early Detection of Lung Cancer
Read time: 5 minutes. Lung cancer screening has come a long way since low-dose CT (LDCT) scans first became available in 2015 in the United States. However, LDCTs can still miss -
New Insights in Treating Metastatic Lung Cancer from WCLC 2025
Read time: 3 minutes. For people with advanced or metastatic non-small cell lung cancer (NSCLC), the treatment landscape has changed dramatically in recent years. Researchers are -
Biggest News in Early-Stage Lung Cancer Research from WCLC 2025
Read time: 2 minutes. The annual World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer, is the largest global meeting -
Small Cell Lung Cancer: Not Small Anymore
Read time: 3 minutes. Small cell lung cancer (SCLC) research continues to progress at an unprecedented rate. Exciting news emerged from the 2025 World Congress on Lung Cancer, with -
Expanding the Reach of Lung Cancer Screening: New Insights from LUNGevity Research
Read time: 2 minutes. Of the more than 234,000 people who will be diagnosed with lung cancer in 2025, roughly 50% are ineligible for lung cancer screening according to current -
Why Do Some People Who Have Never Smoked Get Lung Cancer?
Read time: 3 minutes. As tobacco use has declined in recent years, we have seen a new demographic of lung cancer patients emerge. Lung cancer in individuals who have never smoked -
Leveraging Orphan Drugs for Lung Cancer Treatment
Read time: 4 minutes. As a dedicated researcher and oncologist, Noura Choudhury, MD, at the University of Chicago, witnesses daily the urgent need for better treatments for lung -
Careful Research Investments Yield Big Results
Read time: 3 minutes. When Erin Schenk, MD, PhD, began her journey as a junior faculty member at the University of Colorado, she treated patients with various types of lung cancer -
Conversations that Count: Geriatric Oncology & Engaging the Elderly in Cancer Care
Read time: 2 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts